-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Finch Therapeutics Group, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Finch Therapeutics Group, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $15K, a 95% decline year-over-year.
- Finch Therapeutics Group, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $492K, a 90.8% decline year-over-year.
- Finch Therapeutics Group, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.93M, a 75.4% decline from 2022.
- Finch Therapeutics Group, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.84M, a 88.5% increase from 2021.
- Finch Therapeutics Group, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.16M, a 34.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)